Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi

INTRODUCTION: Pneumonia is the leading infectious killer of children. We conducted a double-blind, randomised controlled non-inferiority trial comparing placebo to amoxicillin treatment for fast breathing pneumonia in HIV-negative children aged 2–59 months in Malawi. Occurrence of serious adverse ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkwopara, Evangelyn, Schmicker, Robert, Mvalo, Tisungane, Phiri, Melda, Phiri, Ajib, Couasnon, Mari, McCollum, Eric D., Ginsburg, Amy Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Paediatric Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733335/
https://www.ncbi.nlm.nih.gov/pubmed/31548894
http://dx.doi.org/10.1136/bmjresp-2019-000415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733335/
https://www.ncbi.nlm.nih.gov/pubmed/31548894
http://dx.doi.org/10.1136/bmjresp-2019-000415

Ejemplares similares